125 related articles for article (PubMed ID: 1468144)
21. The management of transient tyrosinemia of the newborn.
Chase HP; O'Brien D
Pediatrics; 1967 Aug; 40(2):308-9. PubMed ID: 5006599
[No Abstract] [Full Text] [Related]
22. The enzyme defects in hereditary tyrosinaemia type I.
Furukawa N; Hayano T; Sato N; Inoue F; Machida Y; Kinugasa A; Imashuku S; Kusunoki T; Takamatisu T
J Inherit Metab Dis; 1984; 7 Suppl 2():137-8. PubMed ID: 6434869
[No Abstract] [Full Text] [Related]
23. Enzyme defect in a case of tyrosinemia type I, acute form.
Furukawa N; Kinugasa A; Seo T; Ishii T; Ota T; Machida Y; Inoue F; Imashuku S; Kusunoki T; Takamatsu T
Pediatr Res; 1984 May; 18(5):463-6. PubMed ID: 6145143
[TBL] [Abstract][Full Text] [Related]
24. Hereditary tyrosinemia type I: lack of correlation between clinical findings and amount of immunoreactive fumarylacetoacetase protein.
Kvittingen EA; Rootwelt H; van Dam T; van Faassen H; Berger R
Pediatr Res; 1992 Jan; 31(1):43-6. PubMed ID: 1594329
[TBL] [Abstract][Full Text] [Related]
25. [Neonatal transitory tyrosinemia and other types of tyrosinemia].
Lanza I
Minerva Pediatr; 1976 Mar; 28(11):637-43. PubMed ID: 995075
[No Abstract] [Full Text] [Related]
26. [Hereditary tyrosinemia type I].
Endo F
Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):130-3. PubMed ID: 9590006
[No Abstract] [Full Text] [Related]
27. Tyrosinaemia type I with normal levels of plasma tyrosine.
de Almeida IT; Leandro PP; Silva MF; Silveira C; da Silva A; de Sousa JS; Duran M
J Inherit Metab Dis; 1990; 13(3):305-7. PubMed ID: 2122090
[No Abstract] [Full Text] [Related]
28. First-trimester prenatal diagnosis of tyrosinemia type I by amniotic fluid succinylacetone determination.
Jakobs C; Stellaard F; Kvittingen EA; Henderson M; Lilford R
Prenat Diagn; 1990 Feb; 10(2):133-4. PubMed ID: 2343022
[No Abstract] [Full Text] [Related]
29. Chemical analysis of succinylacetone and 4-hydroxyphenyllactate in amniotic fluid using selective ion monitoring.
Jakobs C; Sweetman L; Nyhan WL
Prenat Diagn; 1984; 4(3):187-94. PubMed ID: 6463026
[TBL] [Abstract][Full Text] [Related]
30. Assay of fumarylacetoacetate fumarylhydrolase in human liver-deficient activity in a case of hereditary tyrosinemia.
Kvittingen EA; Jellum E; Stokke O
Clin Chim Acta; 1981 Sep; 115(3):311-9. PubMed ID: 7296877
[TBL] [Abstract][Full Text] [Related]
31. The antenatal diagnosis and aid to the management of hereditary tyrosinaemia by use of a specific and sensitive GC-MS assay for succinylacetone.
Pettit BR; MacKenzie F; King GS; Leonard JV
J Inherit Metab Dis; 1984; 7 Suppl 2():135-6. PubMed ID: 6434868
[No Abstract] [Full Text] [Related]
32. Contribution of extrahepatic tissues to biochemical abnormalities in hereditary tyrosinemia type I: study of three patients after liver transplantation.
Tuchman M; Freese DK; Sharp HL; Ramnaraine ML; Ascher N; Bloomer JR
J Pediatr; 1987 Mar; 110(3):399-403. PubMed ID: 3546650
[TBL] [Abstract][Full Text] [Related]
33. A modified automated fluorometric method for tyrosine determination in blood spotted on paper: a mass screening procedure for tyrosinemia.
Grenier A; Laberge C
Clin Chim Acta; 1974 Nov; 57(1):71-5. PubMed ID: 4430143
[No Abstract] [Full Text] [Related]
34. Detection of succinylacetone and the use of its measurement in mass screening for hereditary tyrosinemia.
Grenier A; Lescault A; Laberge C; Gagné R; Mamer O
Clin Chim Acta; 1982 Aug; 123(1-2):93-9. PubMed ID: 7116642
[TBL] [Abstract][Full Text] [Related]
35. [Hereditary tyrosinemia and alpha-1-fetoprotein. I. Clinical value of alpha-fetoprotein in hereditary tyrosinemia].
Bélanger L; Bélanger M; Prive L; Larochelle J; Tremblay M; Aubin G
Pathol Biol (Paris); 1973 May; 21(5):449-55. PubMed ID: 4125220
[No Abstract] [Full Text] [Related]
36. Genotyping of a case of tyrosinaemia type I with normal level of succinylacetone in amniotic fluid.
Poudrier J; Lettre F; St-Louis M; Tanguay RM
Prenat Diagn; 1999 Jan; 19(1):61-3. PubMed ID: 10073910
[TBL] [Abstract][Full Text] [Related]
37. [Application of succinylacetone levels measurement in the blood and urine in the diagnosis of tyrosinemia type 1].
Han LS; Ye J; Qiu WJ; Zhang HW; Wang Y; Ji WJ; Gao XL; Li XY; Jin J; Gu XF
Zhonghua Er Ke Za Zhi; 2012 Feb; 50(2):126-30. PubMed ID: 22455637
[TBL] [Abstract][Full Text] [Related]
38. Stable isotope dilution analysis of succinylacetone using electron capture negative ion mass fragmentography: an accurate approach to the pre- and neonatal diagnosis of hereditary tyrosinemia type I.
Jakobs C; Dorland L; Wikkerink B; Kok RM; de Jong AP; Wadman SK
Clin Chim Acta; 1988 Feb; 171(2-3):223-31. PubMed ID: 3286060
[TBL] [Abstract][Full Text] [Related]
39. [Tyrosinemia].
Saelzer E; Norero C; Young T
Rev Chil Pediatr; 1980; 51(6):450-3. PubMed ID: 7221079
[No Abstract] [Full Text] [Related]
40. Determination of urinary succinylacetone by capillary gas chromatography.
Tuchman M; Whitley CB; Ramnaraine ML; Bowers LD; Fregien KD; Krivit W
J Chromatogr Sci; 1984 May; 22(5):211-5. PubMed ID: 6725495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
